Bristol Myers to Buy Cancer Drug Developer Rayzebio

Bristol Myers to Buy Cancer Drug Developer Rayzebio

Dec 27, 2023

More Videos

University of Michigan Report Finds that Consumers Aren't Feeling A-Maize-ing, But Rather Blue

Are we at risk for a major recession? For many it feels that way.

Athleisure Brand Rhone Redefines Standards with Women's Launch

After 10 years as a men's wear brand, the popular athleisure brand recently launched its women's line, redefining standards and championing inclusivity.

Americans Want to Save More Money – But Aren’t. Acorns Wants to Help

According to the 2024 Acorns Money Matters Report, nearly a quarter of Americans are worried they could become homeless – and don’t know how easy it is to save.

Three Rate Cuts Coming in 2024? Fingers Crossed

Even with inflation slightly higher than the Federal Reserve's 2% goal, still expect the central bank to cut rates three times this year, Cetera's CIO says.

The Future Of Sports Betting And iGaming

Brian Goodman from Global Matrix Group talks with Dave Briggs about the future of sports betting online and how the popular pastime will evolve. Watch!

Cannabis Rescheduling Could be the ‘First Domino’ to Federal Reform

The Biden administration is set to change marijuana from a Schedule I to Schedule III drug. It could be the first step to sweeping change.

Has Disney Lost the Magic? What Its Latest Results Mean for the Company

Disney's box office and cable results disappoint, but the the House of Mouse is doubling down when it comes to streaming.

Tesla Would Die a Slow and Painful Death as a Strictly EV Company

Tesla is being investigated for allegedly misleading investors about its self-driving capabilities. And one analyst says the company 'needs' that tech to grow.

Trending Now